Ditchcarbon
  • Contact
  1. Organizations
  2. Pt. Tanabe Indonesia
Public Profile
Pharmaceutical Preparation Manufacturing
ID
updated a month ago

Pt. Tanabe Indonesia

Company website

Pt. Tanabe Indonesia, a prominent player in the pharmaceutical industry, is headquartered in Indonesia and operates extensively across Southeast Asia. Founded in 1970, the company has established itself as a leader in the production of high-quality pharmaceutical products, including prescription medications and over-the-counter solutions. With a commitment to innovation and excellence, Pt. Tanabe Indonesia has achieved significant milestones, including the introduction of several unique formulations that cater to local health needs. The company is renowned for its rigorous quality control processes and adherence to international standards, ensuring the safety and efficacy of its offerings. As a subsidiary of Tanabe Seiyaku Co., Ltd., Pt. Tanabe Indonesia has solidified its market position through strategic partnerships and a robust distribution network, making it a trusted name in healthcare across the region.

DitchCarbon Score

How does Pt. Tanabe Indonesia's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

17

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

33

Industry Benchmark

Pt. Tanabe Indonesia's score of 17 is lower than 81% of the industry. This can give you a sense of how well the company is doing compared to its peers.

19%

Let us know if this data was useful to you

Pt. Tanabe Indonesia's reported carbon emissions

In 2016, Pt. Tanabe Indonesia reported total carbon emissions of approximately 98,000,000 kg CO2e. This figure includes 35,447,000 kg CO2e from Scope 1 emissions, which are direct emissions from owned or controlled sources, and 71,805,000 kg CO2e from Scope 2 emissions, representing indirect emissions from the generation of purchased electricity. Additionally, the company reported Scope 3 emissions of about 40,959,000 kg CO2e, specifically from capital goods. Comparatively, in 2015, the total emissions were about 108,000,000 kg CO2e, with Scope 1 emissions at 38,435,000 kg CO2e and Scope 2 emissions at 78,732,000 kg CO2e. The Scope 3 emissions for that year were approximately 34,469,000 kg CO2e. Despite these figures, Pt. Tanabe Indonesia has not established specific reduction targets or initiatives, nor have they committed to any climate pledges or SBTi targets. The absence of documented reduction initiatives suggests a need for enhanced climate action strategies within the organisation. The emissions data is not cascaded from a parent company, indicating that Pt. Tanabe Indonesia operates independently in its reporting and climate commitments.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

20152016
Scope 1
38,435,000
00,000,000
Scope 2
78,732,000
00,000,000
Scope 3
34,469,000
00,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Pt. Tanabe Indonesia's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Pt. Tanabe Indonesia is in ID, which has a very high grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Pt. Tanabe Indonesia is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Bristol-Myers Squibb

US
•
Pharmaceutical Preparation Manufacturing
Updated about 4 hours ago

Sanofi

FR
•
Pharmaceutical Preparation Manufacturing
Updated about 4 hours ago

Regeneron

US
•
Pharmaceutical Preparation Manufacturing
Updated 5 days ago

Amgen

US
•
Pharmaceutical Preparation Manufacturing
Updated about 4 hours ago

Sandoz International GmbH

DE
•
Pharmaceutical Preparation Manufacturing
Updated 2 months ago

Eli Lilly and Company

GB
•
Pharmaceutical Preparation Manufacturing
Updated about 4 hours ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251021.2
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy